These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lipid amphotericin B formulations as comparators in clinical trials. Powers JH; Albrecht R Clin Infect Dis; 2004 Jan; 38(2):305-6; author reply 306-7. PubMed ID: 14699471 [No Abstract] [Full Text] [Related]
3. [Amphotericin B: the end of an era]. Oude Lashof AM; Kullberg BJ Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1665-8. PubMed ID: 15453116 [TBL] [Abstract][Full Text] [Related]
4. Systemic antifungal therapy in pediatric practice. Marwaha RK; Maheshwari A Indian Pediatr; 1999 Oct; 36(10):1011-21. PubMed ID: 10745311 [No Abstract] [Full Text] [Related]
5. [Amphotericin B: the end of an era]. van der Klooster JM; Zandstra DF Ned Tijdschr Geneeskd; 2005 Jan; 149(2):107-8; author reply 108. PubMed ID: 15688846 [No Abstract] [Full Text] [Related]
6. [New antifungal agents. New prospects in the management of systemic mycoses]. Grau Cerrato S; Alvarez-Lerma F; Mateu de Antonio J Farm Hosp; 2003; 27(3):191-8. PubMed ID: 12835822 [No Abstract] [Full Text] [Related]
7. Is there a role for polyenes in treating invasive mycoses? Cornely OA; Vehreschild JJ; Ullmann AJ Curr Opin Infect Dis; 2006 Dec; 19(6):565-70. PubMed ID: 17075332 [TBL] [Abstract][Full Text] [Related]
8. The experience is CLEAR. Chandrasekar P Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():31-5. PubMed ID: 16707248 [TBL] [Abstract][Full Text] [Related]
9. Liposomal amphotericin B found safe and effective. AIDS Patient Care STDS; 1998 Jan; 12(1):69. PubMed ID: 11361899 [No Abstract] [Full Text] [Related]
10. [Amphotericin B: the end of an era]. Rommes JH; Spronk PE; Saene HK Ned Tijdschr Geneeskd; 2005 Jan; 149(2):106; author reply 106-7. PubMed ID: 15688845 [No Abstract] [Full Text] [Related]
13. AmBisome today: expanding the perspectives on liposomal amphotericin B. Richardson M Acta Biomed; 2006; 77 Suppl 2():3-4. PubMed ID: 16918058 [No Abstract] [Full Text] [Related]
14. Amphotericin B deoxycholate: time to retire our old standard? Gallagher JC Expert Rev Anti Infect Ther; 2005 Jun; 3(3):313-6. PubMed ID: 15954845 [No Abstract] [Full Text] [Related]
15. [Drug therapy of mycoses in otorhinolaryngology]. Duminică A Otorinolaringologie; 1972; 17(3):217-9. PubMed ID: 5030473 [No Abstract] [Full Text] [Related]
16. Amphotericin B: is a lipid-formulation gold standard feasible? Spellberg B; Witt MD; Beck CK Clin Infect Dis; 2004 Jan; 38(2):304-5; author reply 306-7. PubMed ID: 14699470 [No Abstract] [Full Text] [Related]
17. Amphotericin B: a commentary on its role as an antifungal agent and as a comparative agent in clinical trials. Gallis HA Clin Infect Dis; 1996 May; 22 Suppl 2():S145-7. PubMed ID: 8722842 [No Abstract] [Full Text] [Related]
19. [Treatment of mycoses with antibiotics]. Vanbreuseghem R Maroc Med; 1971 Mar; 51(544):156-62. PubMed ID: 5562086 [No Abstract] [Full Text] [Related]
20. Is it time to abandon the use of amphotericin B bladder irrigation? Drew RH; Arthur RR; Perfect JR Clin Infect Dis; 2005 May; 40(10):1465-70. PubMed ID: 15844069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]